Programmed death-ligand 1 (PD-L1) expression in various tumor types

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

blogs: 2 blogs

patent: 4 patents

Readers on

mendeley: 57 Mendeley

Summary Blogs Patents

So far, Altmetric has seen 4 patents that reference this research output.

EGFR binding molecules

Grant US-11629193-B2

United States of America

FC binding fragments comprising a PD-L1 antigen-binding site

Grant US-11548948-B2

United States of America

LAG-3 binding members

Grant US-11214618-B2

United States of America

Binding molecules binding PD-L1 and LAG-3

Grant US-11214620-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.